Received May 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
stroke; This serious case was reported by a consumer via interactive digital media and described the occurrence of stroke in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced stroke (Verbatim: stroke) (serious criteria GSK medically significant). The outcome of the stroke was not reported. It was unknown if the reporter considered the stroke to be related to Shingrix. The company considered the stroke to be unrelated to Shingrix. Additional Information: GSK receipt date: 21-MAY-2025 This case was reported by a patient via interactive digital media. Physician gave the first round of Shingrix vaccine to reporter and patient had horrible scary side effects. Patient stated that he/she would not get the second round. Patient heard that it was worst than the first. Patient thought he/she was having a stroke. Patient's husband was getting ready to call an ambulance.; Sender's Comments: Cerebrovascular accident is an unlisted event which is considered unrelated to GSK vaccine Shingrix.